All Stories

  1. Lessons From a Diabetes Clinic: Achieving Glycemic Goals and Clinical Use of Antidiabetic Agents in Patients With Type 2 Diabetes

    Article • Clinical Diabetes, May 2020, American Diabetes Association

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  2. Patients’ and Clinicians’ Preferences on Outcomes and Medication Attributes for Type 2 Diabetes: a Mixed-Methods Study

    Article • Journal of General Internal Medicine, January 2020, Springer Science + Business Media

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  3. Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study

    Article • Indian Journal of Pharmacology, January 2020, Medknow

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  4. Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

    Article • Diabetes Care, September 2019, American Diabetes Association

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  5. Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes

    Article • Diabetes Therapy, June 2019, Springer Science + Business Media

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  6. A rare pulmonary pathology complicated with an unusual condition

    Article • Breathe, June 2019, European Respiratory Society (ERS)

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  7. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies

    Article • BMC Endocrine Disorders, April 2019, Springer Science + Business Media

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  8. Streptococcus thoraltensis Bacteremia: First Described Case as a Fever of Unknown Origin in Human

    Article • Case Reports in Infectious Diseases, December 2018, Hindawi Publishing Corporation

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  9. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial

    Article • Diabetes Obesity and Metabolism, October 2018, Wiley

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  10. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Article • The Lancet, October 2018, Elsevier

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS, Prof. Dr. Bart van Hoek

  11. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

    Article • The Lancet Diabetes & Endocrinology, April 2018, Elsevier

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  12. Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

    Article • Diabetes Care, December 2017, American Diabetes Association

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS

  13. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

    Article • New England Journal of Medicine, November 2015, New England Journal of Medicine (NEJM/MMS)

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS, Professor Dmitry Zateyshchikov